Cargando…

Obesity-induced pancreatopathy in rats is reversible after bariatric surgery

Obesity is a risk factor for pancreatic diseases. Bariatric surgery is one of the most efficient treatments of morbid obesity. The aims were to assess pancreatic endocrine and exocrine lesions in obese rats, to analyze effects of bariatric surgery. Sixty-three male Wistar rats were included in five...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebours, Vinciane, Garteiser, Philippe, Ribeiro-Parenti, Lara, Cavin, Jean-Baptiste, Doblas, Sabrina, Pagé, Gwenaël, Bado, André, Couvineau, Alain, Ruszniewski, Philippe, Paradis, Valérie, Le Gall, Maude, Van Beers, Bernard E., Couvelard, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214994/
https://www.ncbi.nlm.nih.gov/pubmed/30390093
http://dx.doi.org/10.1038/s41598-018-34515-3
_version_ 1783368054329049088
author Rebours, Vinciane
Garteiser, Philippe
Ribeiro-Parenti, Lara
Cavin, Jean-Baptiste
Doblas, Sabrina
Pagé, Gwenaël
Bado, André
Couvineau, Alain
Ruszniewski, Philippe
Paradis, Valérie
Le Gall, Maude
Van Beers, Bernard E.
Couvelard, Anne
author_facet Rebours, Vinciane
Garteiser, Philippe
Ribeiro-Parenti, Lara
Cavin, Jean-Baptiste
Doblas, Sabrina
Pagé, Gwenaël
Bado, André
Couvineau, Alain
Ruszniewski, Philippe
Paradis, Valérie
Le Gall, Maude
Van Beers, Bernard E.
Couvelard, Anne
author_sort Rebours, Vinciane
collection PubMed
description Obesity is a risk factor for pancreatic diseases. Bariatric surgery is one of the most efficient treatments of morbid obesity. The aims were to assess pancreatic endocrine and exocrine lesions in obese rats, to analyze effects of bariatric surgery. Sixty-three male Wistar rats were included in five groups: 2 fed with high fat diet (HFD) or normal diet for 3 months, 2 fed with HFD or normal diet for 6 months; 1 group fed with HFD and undergoing bariatric surgery (n = 30). Quantitative MR imaging was performed in HFD(6), ND(6) and HFD(3)-BS. Pancreas specimens were analyzed after sacrifice for adipocyte infiltration, fibrosis, acinar-ductal metaplasia, abnormality of Langerhans islets (HHF: hypertrophy, hypervascularisation, fibrosis), and hemosiderin deposits in acinar or endocrine locations. We found that HFD(6) rats had more fibro-inflammatory islets (P = 0.0139) and acinar-ducal metaplasia (P = 0.0843) than HFD(3) rats. Rats with HFD(3+6) had more fibro-inflammatory islets (P < 0.0001), hemosiderin deposits (p < 0.0001), fat infiltration (P = 0.0008) and acinar-ductal metaplasia lesions (P = 0.0424). Weight increase was associated with glycoregulation abnormalities (r = 0.44, P = 0.08) and adipocyte infiltrations (P = 0.009). After surgery, less fibro-inflammatory islets (P = 0.0004), fat and iron infiltrates (P = 0.005 and P = 0.06), and acino-ductal metaplasia (P = 0.05) were observed compared to HFD(6) rats. MR image quantifications revealed increased elasticity, fat fraction, and R2 and a decreased elasticity wave dispersion coefficient in the high fat groups that reversed after surgery. MRI parameters were in strong correlation with respective histological counterparts. In conclusion, obese rats develop pancreatic inflammatory lesions with acinar-ductal metaplasia in acinar location and the endocrine-exocrine interface. These changes can be prevented by bariatric surgery. Quantitative MR imaging is accurate in identifying early pancreatic lesions.
format Online
Article
Text
id pubmed-6214994
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62149942018-11-06 Obesity-induced pancreatopathy in rats is reversible after bariatric surgery Rebours, Vinciane Garteiser, Philippe Ribeiro-Parenti, Lara Cavin, Jean-Baptiste Doblas, Sabrina Pagé, Gwenaël Bado, André Couvineau, Alain Ruszniewski, Philippe Paradis, Valérie Le Gall, Maude Van Beers, Bernard E. Couvelard, Anne Sci Rep Article Obesity is a risk factor for pancreatic diseases. Bariatric surgery is one of the most efficient treatments of morbid obesity. The aims were to assess pancreatic endocrine and exocrine lesions in obese rats, to analyze effects of bariatric surgery. Sixty-three male Wistar rats were included in five groups: 2 fed with high fat diet (HFD) or normal diet for 3 months, 2 fed with HFD or normal diet for 6 months; 1 group fed with HFD and undergoing bariatric surgery (n = 30). Quantitative MR imaging was performed in HFD(6), ND(6) and HFD(3)-BS. Pancreas specimens were analyzed after sacrifice for adipocyte infiltration, fibrosis, acinar-ductal metaplasia, abnormality of Langerhans islets (HHF: hypertrophy, hypervascularisation, fibrosis), and hemosiderin deposits in acinar or endocrine locations. We found that HFD(6) rats had more fibro-inflammatory islets (P = 0.0139) and acinar-ducal metaplasia (P = 0.0843) than HFD(3) rats. Rats with HFD(3+6) had more fibro-inflammatory islets (P < 0.0001), hemosiderin deposits (p < 0.0001), fat infiltration (P = 0.0008) and acinar-ductal metaplasia lesions (P = 0.0424). Weight increase was associated with glycoregulation abnormalities (r = 0.44, P = 0.08) and adipocyte infiltrations (P = 0.009). After surgery, less fibro-inflammatory islets (P = 0.0004), fat and iron infiltrates (P = 0.005 and P = 0.06), and acino-ductal metaplasia (P = 0.05) were observed compared to HFD(6) rats. MR image quantifications revealed increased elasticity, fat fraction, and R2 and a decreased elasticity wave dispersion coefficient in the high fat groups that reversed after surgery. MRI parameters were in strong correlation with respective histological counterparts. In conclusion, obese rats develop pancreatic inflammatory lesions with acinar-ductal metaplasia in acinar location and the endocrine-exocrine interface. These changes can be prevented by bariatric surgery. Quantitative MR imaging is accurate in identifying early pancreatic lesions. Nature Publishing Group UK 2018-11-02 /pmc/articles/PMC6214994/ /pubmed/30390093 http://dx.doi.org/10.1038/s41598-018-34515-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rebours, Vinciane
Garteiser, Philippe
Ribeiro-Parenti, Lara
Cavin, Jean-Baptiste
Doblas, Sabrina
Pagé, Gwenaël
Bado, André
Couvineau, Alain
Ruszniewski, Philippe
Paradis, Valérie
Le Gall, Maude
Van Beers, Bernard E.
Couvelard, Anne
Obesity-induced pancreatopathy in rats is reversible after bariatric surgery
title Obesity-induced pancreatopathy in rats is reversible after bariatric surgery
title_full Obesity-induced pancreatopathy in rats is reversible after bariatric surgery
title_fullStr Obesity-induced pancreatopathy in rats is reversible after bariatric surgery
title_full_unstemmed Obesity-induced pancreatopathy in rats is reversible after bariatric surgery
title_short Obesity-induced pancreatopathy in rats is reversible after bariatric surgery
title_sort obesity-induced pancreatopathy in rats is reversible after bariatric surgery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214994/
https://www.ncbi.nlm.nih.gov/pubmed/30390093
http://dx.doi.org/10.1038/s41598-018-34515-3
work_keys_str_mv AT reboursvinciane obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT garteiserphilippe obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT ribeiroparentilara obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT cavinjeanbaptiste obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT doblassabrina obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT pagegwenael obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT badoandre obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT couvineaualain obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT ruszniewskiphilippe obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT paradisvalerie obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT legallmaude obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT vanbeersbernarde obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery
AT couvelardanne obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery